Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupport
Contact Us
Search
Close

COVID-19 Update: CDC Increasing Sequencing for Virus Variants

By Yvonne Puig (US), Daphne Calderon (US) & Jeff Wurzburg (US) on February 26, 2021
Email this postTweet this postLike this postShare this post on LinkedIn

The Biden Administration recently announced additional funding to increase genomic sequencing of COVID-19 to 25,000 samples a week.  In a recent article in the Journal for the American Medical Association, U.S. Centers for Disease Control and Prevention (“CDC”) Director Rochelle Walensky and Dr. Anthony Fauci of the U.S. National Institute of Allergy and Infectious Diseases warned that “[t]he public health response within the US needs to address not only SARS-COV-2 variants from other countries, but also be vigilant for the evolution of domestic VOC given the high level transmission in much of the nation.”  The U.S. is presently analyzing 14,000 cases per week, a significant increase from just last month.

On February 24, 2021 President Biden continued the National Emergency declared on March 13, 2020 under section 202(d) of the National Emergencies Act.  The U.S. recently surpassed 500,000 deaths related to COVID-19.

The White House COVID-19 response team has announced that the U.S. government will send 25 million cloth masks to community health centers and food pantries.  In remarks on February 25, President Biden referenced the increasing pace of vaccination in the U.S., with over 12 million shots being administered in the next week.  He also stated that vaccine distribution to states has increased by 70 percent and that close to 50 percent of individuals over the age of 65 have received at least one COVID-19 vaccine dose.

On February 24, 2021 the U.S. Department of Health and Human Services (“HHS”) Office for Civil Rights published in the Federal Register that it will use enforcement discretion and will not impose penalties where health care providers have used online or web-based scheduling applications (“WSBA”) for COVID-19 vaccination appointments in good faith.  This enforcement discretion will last until the conclusion of the public health emergency.  HHS stated that providers must still use “reasonable safeguards to protect the privacy and security of individuals’ personal health information.”  HHS recommends the following safeguards:

  • Using and disclosing only the minimum PHI necessary for the purpose (e.g., an individual’s name and phone number may be the minimum necessary PHI for scheduling the appointment).
  • Using encryption technology to protect PHI.
  • Enabling all available privacy settings (e.g., adjusting WSBA calendar display settings, as needed, to hide names or show only individuals’ initials instead of full names on calendar screens).
  • Ensuring that storage of any PHI (including metadata that constitutes PHI) by the vendor is only temporary (e.g., the PHI is returned to the covered health care provider or destroyed as soon as practicable, but no later than 30 days after the appointment).

Enforcement Discretion Regarding Online or Web-Based Scheduling Applications for the Scheduling of Individual Appointments for COVID-19 Vaccination During the COVID-19 Nationwide Public Health Emergency, 86 Fed. Reg. 11139, 11141 (Feb. 24, 2021).  The enforcement discretion does not apply to activities other than scheduling COVID-19 vaccines.

Norton Rose Fulbright lawyers will continue to provide relevant updates on the COVID-19 PHE on the Health Law Pulse.

Photo of Yvonne Puig (US) Yvonne Puig (US)

US Head of Life Sciences and Healthcare Yvonne Puig has a substantial commercial litigation practice in both state and federal courts. She represents hospitals, HMOs, managed care organizations, medical schools and other institutional health care providers and educational services companies. A partner in…

US Head of Life Sciences and Healthcare Yvonne Puig has a substantial commercial litigation practice in both state and federal courts. She represents hospitals, HMOs, managed care organizations, medical schools and other institutional health care providers and educational services companies. A partner in Norton Rose Fulbright’s Austin office, Yvonne’s practice involves commercial and health care litigation, antitrust, regulatory and compliance advice, crisis management, staff privileges, exclusive contracting and administrative law.

Read more about Yvonne Puig (US)Email
Show more Show less
Photo of Daphne Calderon (US) Daphne Calderon (US)
Read more about Daphne Calderon (US)Email
Photo of Jeff Wurzburg (US) Jeff Wurzburg (US)
Read more about Jeff Wurzburg (US)Email
  • Posted in:
    Health Care and Life Sciences
  • Blog:
    Health Law Pulse
  • Organization:
    Norton Rose Fulbright
  • Article: View Original Source

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS
  • About LexBlog
  • The Field We Built
  • Our Beliefs
  • Our Team
  • Contact LexBlog
  • Disclaimer
  • Editorial Policy
  • Terms of Service
  • Get Started
  • Publishing Solutions
  • Compass
  • Submit a Request
  • Support Center
  • System Status
Copyright © 2026, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo